These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2731324)

  • 1. Patient acceptance of transdermal clonidine. A retrospective review of 25 patients.
    Chen SW; Vidt DG
    Cleve Clin J Med; 1989; 56(1):21-6. PubMed ID: 2731324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
    Lewis GR
    N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal clonidine compared with hydrochlorothiazide as monotherapy in elderly hypertensive males.
    Schmidt GR; Schuna AA; Goodfriend TL
    J Clin Pharmacol; 1989 Feb; 29(2):133-9. PubMed ID: 2715369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A community-based trial of transdermal antihypertensive therapy with clonidine (Catapres-TTS).
    Kellaway GS; Lubbe WF
    N Z Med J; 1986 Sep; 99(810):711-4. PubMed ID: 3547202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of transcutaneous clonidine hydrochloride in the patient with diabetes mellitus and mild hypertension.
    Wallin JD; Krane NK; Bergman S; Morgan M
    J Clin Hypertens; 1985 Dec; 1(4):315-21. PubMed ID: 3836300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal and oral clonidine.
    Lilja M; Juustila H; Sarna S; Jounela AJ
    Ann Med; 1991 Aug; 23(3):265-9. PubMed ID: 1930916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with transdermal clonidine in mild hypertension.
    Fillingim JM; Matzek KM; Hughes EM; Johnson PA; Sharon GS
    Clin Ther; 1989; 11(3):398-408. PubMed ID: 2743374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal clonidine therapy in elderly mild hypertensives: effects on blood pressure, plasma norepinephrine and fasting plasma glucose.
    Klein C; Morton N; Kelley S; Metz S
    J Hypertens Suppl; 1985 Dec; 3(4):S81-4. PubMed ID: 3868715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance].
    Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1841-5. PubMed ID: 6676936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine through the skin in the treatment of essential hypertension: is it practical?
    Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
    J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal clonidine application: long-term results in essential hypertension.
    Groth H; Vetter H; Knüsel J; Foerster E; Siegenthaler W; Vetter W
    Klin Wochenschr; 1984 Oct; 62(19):925-30. PubMed ID: 6503214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal clonidine therapy and blood pressure nocturnal fall in mild hypertensive male subjects.
    Guagnano MT; Pace Palitti V; Merlitti D; Carrabs C; Santucci E; Sensi S
    Clin Exp Hypertens; 1997 Apr; 19(3):331-41. PubMed ID: 9107440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension.
    Breidthardt J; Schumacher H; Mehlburger L
    Clin Auton Res; 1993 Dec; 3(6):385-90. PubMed ID: 8193526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
    Lowenthal DT; Saris S; Paran E; Cristal N; Sharif K; Bies C; Fagan T
    Am Heart J; 1986 Oct; 112(4):893-900. PubMed ID: 3532747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal administration of clonidine: a new approach to antihypertensive therapy.
    Burris JF; Mroczek WJ
    Pharmacotherapy; 1986; 6(1):30-4. PubMed ID: 3952004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects.
    Fujimura A; Ebihara A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1994 Mar; 34(3):260-5. PubMed ID: 8021335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
    Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
    Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension by a new transdermal form of clonidine.
    Gosse P; Wicker P; Roudaut R; Danays T; Dallocchio M
    J Hypertens Suppl; 1985 Dec; 3(4):S65-7. PubMed ID: 3868714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
    Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
    Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the antihypertensive effect of TTS clonidine by multiple 24-hour automatic blood pressure monitoring.
    Mancia G; Parati G; Pomidossi G; Malaspina D; Colombo A; Camesasca C; Groppelli A; Casadei R; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S187-93. PubMed ID: 2455177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.